Adel, Inc.
PrivateLast Round
Private Equity
Apr 9, 2026
Est. Valuation
$277.5M
Total Funding Raised
$56.02M
Company Overview
Adel, Inc. is a biopharmaceutical company that develops therapeutic antibodies and diagnostic systems for neurodegenerative diseases, with a primary focus on Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adel, Inc. Comparables
Compare Adel, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oscotec Inc | 83% | |
| Amyloid Solution Inc. | 79% | |
| Prothena Corporation plc | 78% | |
Adel, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Apr 9, 2026 | ||||
| Series B Extension | Jul 31, 2024 | ||||
| Series B | Oct 1, 2020 |
Adel, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series B Extension, Private Equity |
| Korea Investment Partners | Private Equity |
| Samsung Securities | Private Equity |
| DS Asset Management | Private Equity |
| Mirae Asset Securities | Private Equity |
| Timefolio Asset Management | Private Equity |
| Samsung Venture Investment | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 50% QoQ, from 6 to 9 employees.
- Apr 12, 2026
Grew 80% QoQ from 5 to 9 employees.
Adel, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adel, Inc.'s valuation, stock price, and market status.